115 related articles for article (PubMed ID: 38565395)
1. All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment.
Ding Y; Xu Q; Chai Z; Wu S; Xu W; Wang J; Zhou J; Luo Z; Liu Y; Xie C; Lu L; Lu W
J Control Release; 2024 May; 369():325-334. PubMed ID: 38565395
[TBL] [Abstract][Full Text] [Related]
2. Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma.
Chai Z; Ran D; Lu L; Zhan C; Ruan H; Hu X; Xie C; Jiang K; Li J; Zhou J; Wang J; Zhang Y; Fang RH; Zhang L; Lu W
ACS Nano; 2019 May; 13(5):5591-5601. PubMed ID: 31070352
[TBL] [Abstract][Full Text] [Related]
3. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
Wu S; Lu L; Zhou J; Ran D; Wang S; Xu Q; Xu W; Wang J; Liu Y; Xie C; Luo Z; Lu W
J Control Release; 2022 May; 345():685-695. PubMed ID: 35346767
[TBL] [Abstract][Full Text] [Related]
4. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
5. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
6. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.
Chai Z; Hu X; Wei X; Zhan C; Lu L; Jiang K; Su B; Ruan H; Ran D; Fang RH; Zhang L; Lu W
J Control Release; 2017 Oct; 264():102-111. PubMed ID: 28842313
[TBL] [Abstract][Full Text] [Related]
7. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
8. Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
Fan R; Chuan D; Hou H; Chen H; Han B; Zhang X; Zhou L; Tong A; Xu J; Guo G
Nanoscale; 2019 Jun; 11(23):11285-11304. PubMed ID: 31165845
[TBL] [Abstract][Full Text] [Related]
9. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
10. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
11. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
[TBL] [Abstract][Full Text] [Related]
12. Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor.
Shaw TK; Mandal D; Dey G; Pal MM; Paul P; Chakraborty S; Ali KA; Mukherjee B; Bandyopadhyay AK; Mandal M
Drug Deliv; 2017 Nov; 24(1):346-357. PubMed ID: 28165821
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma.
Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH
ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735
[TBL] [Abstract][Full Text] [Related]
14. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
[TBL] [Abstract][Full Text] [Related]
15. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
16. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
[No Abstract] [Full Text] [Related]
17. Combined integrin α
Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
19. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.
Xu L; Wu S; Zhou X
J Biomater Appl; 2018 Jul; 33(1):72-81. PubMed ID: 29699442
[TBL] [Abstract][Full Text] [Related]
20. A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy.
Zhang Y; Xia Q; Wu T; He Z; Li Y; Li Z; Hou X; He Y; Ruan S; Wang Z; Sun J; Feng N
J Nanobiotechnology; 2021 Aug; 19(1):245. PubMed ID: 34391438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]